業績|論文・出版物|目次|ALL
Inhibition of CRISPR/Cas9-mediated genome engineering by a type I interferon-induced reduction in guide RNA expression
Machitani M.#, Sakurai F.#, Wakabayashi K., Nakatani K., Takayama K., Tachibana M., Mizuguchi H. #These authors equally contributed to this work. (Highlighted paper selected by Editor-in-Chief)
Biol. Pharm. Bull., 40, 272-277 (2017)
Enhanced oncolytic activities of the telomerase-specific replication-competent adenovirus expressing short-hairpin RNA against Dicer
Machitani M.#, Sakurai F.#, Wakabayashi K., Tachibana M., Fujiwara T., Mizuguchi H. #These authors equally contributed to this work.
Mol. Cancer Ther., 16, 251-259 (2017)
Type I interferons impede short-hairpin RNA-mediated RNA interference via inhibition of dicer-mediated processing to small interfering RNA
Machitani M.#, Sakurai F.#, Wakabayashi K., Takayama K., Tachibana M., Mizuguchi H. #These authors equally contributed to this work.
Mol. Ther. Nucleic Acids, 6, 173-182 (2017)
Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus
Sakurai F., Narii N., Tomita K., Togo S., Takahashi K., Machitani M., Tachibana M., Ouchi M., Katagiri N., Urata Y., Fujiwara T., Mizuguchi H.
Mol. Ther. Methods Clin. Dev., 3, 16001 (2016)
Laminin 411 and 511 promote the cholangiocyte differentiation of human induced pluripotent stem cells
Takayama K.#, Mitani S.#, Nagamoto Y., Sakurai F., Tachibana M., Taniguchi Y., Sakaguchi K., Mizuguchi H. #These authors equally contributed to this work.
